Adtec Healthcare

What Adtec Healthcare does

Adtec Healthcare Limited is a UK-based, privately held medical technology company headquartered in Twickenham that develops and commercializes the SteriPlas Premium Cold Plasma medical device for hospital use. The company was incorporated in June 2023 as a spin-out from Japan's Adtec Plasma Technology Co., Ltd., which has pioneered plasma innovation for over 30 years. Adtec Healthcare targets hospitals and specialty clinics treating chronic wound infections (diabetic foot ulcers, pressure ulcers, vascular ulcers) and surgical site infections (including LVAD driveline infections and burns), where biofilm-protected and antibiotic-resistant bacteria render standard therapies ineffective. The device is sold enterprise-style through a contact-based eligibility and evaluation process followed by hospital lease or purchase decisions, supplemented by a global distributor partnership strategy and major medical conference presence (EWMA, MEDICA, DPC, DFSG, ISMCS, MedTech World Middle East, WHX Dubai, JP Morgan Healthcare Conference).

SteriPlas is built on proprietary 2.45 GHz microwave technology applied to pure argon gas, producing a cool, high-density plasma stream rich in ions, electrons, and reactive species that physically penetrates biofilm and ruptures bacterial cell walls. The company claims this physical mode of action prevents the development of bacterial resistance and has been clinically shown to reduce bacterial load by 73.5%, deliver up to 100% wound size and depth reduction, and produce zero reported adverse events across 10,000+ treatments and 85+ peer-reviewed publications accumulated over 18+ years of clinical experience. The device is regulated as a Class IIa medical device in the EU under MDR (certified May 2025), and the company is pursuing FDA approval for US entry. Single-product focus limits platform optionality but concentrates clinical evidence generation on one well-validated mechanism.

The business model combines hardware sales (device lease or purchase to hospitals) with associated professional services including training, clinical support, and outcome tracking. Adtec is led by CEO Mary McGovern, CTO Francois Herbst (20+ years in plasma technology), and CBDO Jeiram Jeyaratnam. The company secured $12 million in strategic investment in July 2025 led by AIPO Fund with co-investor SG Biomedical, earmarked for global expansion, next-generation device development, and US market entry. The company is headquartered in Twickenham, UK, with active markets or clinical engagement in Europe, Taiwan, Austria, Romania, the UAE/MENA, and Japan via the parent, while pursuing US entry.

Name

Adtec Healthcare

Legal name

Adtec Healthcare Limited

Website

https://adtechealthcare.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Short description

Adtec Healthcare Limited is a UK-based medical device company that develops and sells SteriPlas, a Premium Cold Plasma system using 2.45 GHz microwave and argon gas to treat chronic wound and surgical site infections in hospitals and specialty clinics.

Ownership category

akta.pro rank

Product category

Wound Care Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Irradiation Apparatus Manufacturing (334517)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser) (HLAHADAC)

Keywords

• Cold plasma therapy
• Wound care devices
• Biofilm treatment
• Infection management
• Surgical site treatment

Headquarters

HQ city

Twickenham

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Operations, Supply Chain, Marketing or Sales, Personnel

Revenue model

1. Medical Device Sales (SteriPlas): Sale of SteriPlas Premium Cold Plasma medical device to hospitals and healthcare providers. Sales process includes evaluation period, then options to lease or buy the device.
2. Treatment Services/Support: Full training, clinical support, and outcome tracking throughout evaluation and ongoing use. Revenue generated through device sales with associated service and support components.

Pricing tiers

Go-to-market motion3 records

Distribution channels2 records

Marketing channels5 records

Core offering

Adtec Healthcare designs, manufactures, and commercializes the SteriPlas Premium Cold Plasma medical device, which uses proprietary 2.45 GHz microwave technology applied to pure argon gas to produce a cool, high-density plasma stream that penetrates biofilm, destroys resistant bacteria, and accelerates healing in chronic wound infections and surgical site infections. The device is sold or leased to hospitals and clinics, accompanied by full clinical training, evaluation support, and outcome tracking services.

Product overview

Adtec Healthcare offers a single unified product — the SteriPlas Premium Cold Plasma medical device. This device uses proprietary microwave 2.45GHz technology with pure argon gas to produce a cool, high-density plasma stream that penetrates biofilms and destroys resistant bacteria without harming healthy tissue. The company provides this one core product along with associated clinical support, training, and outcome tracking services for hospitals and clinics. Adtec Healthcare was founded from Adtec Plasma Technology Japan (30+ years of plasma innovation) and spun out as a UK entity in June 2023, with over 18 years of clinical experience and 10,000+ treatments worldwide supporting the product.

Differentiator

Problem solved

Functional benefit

Brands

• SteriPlas: Premium Cold Plasma medical device for chronic wound care and infection management. Uses microwave 2.45 GHz technology with argon gas to produce cold plasma that penetrates biofilms, destroys resistant bacteria, and accelerates wound healing. Clinically proven to reduce bacterial load by 73.5% and decrease wound size/depth by up to 100%.

Products and services

• SteriPlas Premium Cold Plasma Medical Device A hospital-grade medical device that uses proprietary 2.45 GHz microwave technology applied to pure argon gas to generate a cool, high-density atmospheric plasma stream rich in reactive species. The device penetrates biofilm and physically destroys gram-negative, gram-positive, and biofilm-protected bacteria without developing resistance, treating chronic wound infections (e.g., diabetic foot ulcers, pressure ulcers, vascular ulcers) and surgical site infections (e.g., LVAD driveline infections). It is sold or leased to hospitals and clinics with bundled training, clinical support, and outcome tracking.

Quantifiable outcome

• 73.5% reduction in bacterial load
• +6 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Adtec Plasma Technology Co., Ltd. (Japan)coreStrategic or Co-development PartnerParent company from which Adtec Healthcare Limited spun out in June 2023. Pioneers in plasma innovation for over 30 years. Company introduced world's first clinical trials using Premium Plasma for chronic wounds.
• ABHI (Association of British HealthTech Industries)minorGTM or Marketing PartnerAdtec Healthcare exhibiting on ABHI UK Pavilion at WHX Dubai, connecting with distributor partners and healthcare professionals from across MENA region.
• FieldFisher LondonminorImplementation/ SI/ Consulting PartnerLegal counsel provided by FieldFisher London on the $12 million investment transaction from AIPO Fund and SG Biomedical.
• Medilink UK InternationalminorGTM or Marketing PartnerAdtec Healthcare exhibiting on Medilink UK International UK Pavilion at MEDICA, connecting with industry partners, active distributors, and those seeking to introduce SteriPlas to their regions.
• PodymosminorGTM or Marketing PartnerMarketing and communications agency partner assisting with product photography and visual content for SteriPlas Premium Cold Plasma medical device.

Scale indicators9 records

Recent moves7 records

Expansion highlights7 records

Broad incumbents

• Apyx Medical (Renuvion): Apyx Medical sells helium-based plasma/RF surgical generators (Renuvion, former J-Plasma). Comparable as an energy-based plasma medical device company commercializing cold plasma technology for clinical use cases; broader portfolio covering cosmetic surgery, not solely wound care.
• Smith & Nephew: Global medical devices leader with a large Advanced Wound Management franchise (ALLEVYN, PICO negative pressure wound therapy). Comparable as a dominant wound care incumbent whose portfolio competes for the same hospital budget line items Adtec targets with SteriPlas.
• ConvaTec: Global wound care specialist offering Avelle negative pressure therapy, AQUACEL dressings, and infection management products. Comparable as a major chronic wound care incumbent competing for the diabetic foot ulcer and surgical site infection segments Adtec addresses.
• Mölnlycke Health Care: Swedish wound care and surgical solutions company (Mepilex, Avance, single-use OR products). Comparable as a hospital-focused wound care incumbent with strong European distribution that Adtec's distributor channel must contend with.
• Coloplast: Danish medical devices company with a significant Wound & Skin Care business (Biatain, Comfeel). Comparable as a European-based wound care incumbent directly competing for hospital contracts in the same chronic wound care category.
• Ethicon (Johnson & Johnson MedTech): Global energy-based surgical device leader (e.g., HARMONIC, ENSEAL electrosurgery). Comparable as an established energy-based surgical device manufacturer whose portfolio overlaps with the plasma/energy wound treatment positioning of SteriPlas and which could pursue or license competitive plasma-based wound adjuncts.

Emerging players

• neoplas med GmbH: German developer of cold atmospheric plasma technology (kINPen and related devices) for wound healing, dermatology, and oncology. Directly comparable as a cold plasma medical device peer focused on chronic wound care and infection management; smaller, research-oriented footprint.
• Cinogy GmbH: German company developing plasma jet dermatology devices (e.g., PlasmaJet system) for skin and wound indications. Comparable cold plasma medical device peer with overlapping clinical focus areas, though with a wider aesthetic/dermatology emphasis.
• RenovaCare: US-listed regenerative medicine company developing technologies (SkinGun, CellMist) for wound and burn treatment. Comparable as an emerging advanced wound care player pursuing novel non-pharmaceutical tissue repair modalities, including plasma-assisted approaches.
• Organogenesis: US-listed regenerative medicine company (Apligraf, Dermagraft) focused on advanced wound care for diabetic foot ulcers and venous leg ulcers. Comparable as a specialized advanced wound care player competing in the same chronic wound indications Adtec targets, though using cellular constructs rather than plasma.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/results?search_query=Adtec+Healthcare
• LinkedInlinkedin.com/company/adtec-healthcare-limited
• Facebookfacebook.com/adtechealthcare

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Adtec Healthcare